Skip to main content
. Author manuscript; available in PMC: 2022 Jun 6.
Published in final edited form as: Ann Epidemiol. 2022 Apr 6;70:23–31. doi: 10.1016/j.annepidem.2022.03.016

Table 2.

Relative Risk Ratios (RRR) for prevention-effective adherence trajectory among transgender women indicated for and/or using PrEP in the LITE cohort (N=540)

Unadjusted Relative Risk Ratios Adjusted Relative Risk Ratios
Reference Group: Group 4: Consistent indication/PrEP adherent RRR P-value 95% CI aRRR P-value 95% CI

Group 1: Consistent indication/no PrEP

Youth (Aged 18–24) 1.18 0.67 0.56 2.5 1.18 0.69 0.52 2.66
Black 0.98 0.95 0.53 1.81 0.62 0.25 0.28 1.40
Latina 0.78 0.44 0.41 1.48 0.47 0.06 0.21 1.04
Census division (ref=New England)
 Mid-Atlantic 0.80 0.66 0.30 2.12 0.92 0.88 0.31 2.69
 South Atlantic 0.97 0.94 0.40 2.36 1.02 0.96 0.37 2.86
College education or higher (ref=high school diploma/GED or less) 0.57 0.08 0.30 1.07 0.63 0.22 0.30 1.31
Homelessness 1.69 0.16 0.82 3.51 2.07 0.09 0.88 4.82
Arrest 2.81 0.07 0.92 8.59 2.56 0.16 0.69 9.52
Uninsured 2.52 0.05 1.00 6.32 1.47 0.48 0.51 4.24
Lab-confirmed STI 2.37 0.01 1.22 4.61 2.54 0.02 1.16 5.57
1 or more current partner using PrEP 0.25 <0.001 0.13 0.47 0.18 <0.001 0.09 0.36
6+ months since last healthcare encounter 4.90 <0.01 1.53 15.71 5.66 0.02 1.40 22.85
Anticipated discrimination in healthcare 0.90 0.73 0.49 1.64 1.02 0.95 0.50 2.07
Group 2: Initial indication/no PrEP

Youth (Aged 18–24) 2.90 <0.001 1.64 5.11 3.04 <0.001 1.60 5.78
Black 0.78 0.32 0.49 1.26 0.62 0.14 0.33 1.17
Latina 0.80 0.38 0.49 1.31 0.71 0.27 0.39 1.30
Census division (ref=New England)
 Mid-Atlantic 0.66 0.26 0.32 1.36 0.73 0.45 0.32 1.67
 South Atlantic 0.52 0.06 0.26 1.04 0.8 0.58 0.36 1.78
College education or higher (ref=high school diploma/GED or less) 0.69 0.16 0.42 1.15 0.9 0.75 0.49 1.67
Homelessness 1.66 0.09 0.92 2.99 1.87 0.10 0.89 3.94
Arrest 1.31 0.61 0.47 3.65 1.03 0.97 0.28 3.81
Uninsured 1.50 0.33 0.66 3.4 1.52 0.38 0.59 3.91
Lab-confirmed STI 0.43 <0.01 0.23 0.8 0.45 0.03 0.21 0.94
1 or more current partner using PrEP 0.19 <0.001 0.12 0.31 0.15 <0.001 0.09 0.27
6+ months since last healthcare encounter 1.88 0.26 0.62 5.67 2.1 0.29 0.54 8.21
Anticipated discrimination in healthcare 0.89 0.64 0.56 1.43 0.83 0.51 0.46 1.47
Group 3: Declining indication/discontinued PrEP

Youth (Aged 18–24) 2.00 0.08 0.92 4.36 1.48 0.38 0.62 3.56
Black 1.26 0.50 0.64 2.50 0.81 0.63 0.34 1.93
Latina 1.06 0.87 0.52 2.16 0.82 0.64 0.36 1.88
Census division (ref=New England)
 Mid-Atlantic 1.15 0.79 0.41 3.25 1.32 0.64 0.41 4.23
 South Atlantic 0.65 0.40 0.24 1.78 0.88 0.83 0.28 2.80
College education or higher (ref=high school diploma/GED or less) 0.26 <0.001 0.13 0.53 0.28 <0.01 0.13 0.63
Homelessness 2.78 <0.01 1.29 5.99 2.71 0.03 1.10 6.70
Arrest 0.78 0.78 0.15 4.19 0.91 0.92 0.15 5.62
Uninsured 0.87 0.83 0.25 3.05 0.76 0.69 0.20 2.93
Lab-confirmed STI 1.11 0.79 0.5 2.49 1.03 0.95 0.41 2.60
1 or more current partner using PrEP 0.65 0.21 0.33 1.28 0.59 0.18 0.28 1.27
6+ months since last healthcare encounter 0.95 0.95 0.17 5.37 1.79 0.54 0.27 11.8
Anticipated discrimination in healthcare 0.94 0.87 0.47 1.88 1.01 0.98 0.46 2.23
Group 5: Increasing indication/initiated PrEP

Youth (Aged 18–24 at enrollment) 2.61 0.02 1.21 5.66 2.15 0.09 0.90 5.15
Black 1.90 0.07 0.94 3.84 1.5 0.37 0.62 3.66
Latina 0.75 0.46 0.36 1.59 0.64 0.33 0.26 1.56
Census division (ref=New England)
 Mid-Atlantic 0.73 0.58 0.25 2.17 0.81 0.74 0.24 2.80
 South Atlantic 0.80 0.66 0.3 2.16 0.88 0.84 0.27 2.91
College education or higher (ref=high school diploma/GED or less) 0.44 0.03 0.22 0.9 0.65 0.31 0.28 1.49
Homelessness 2.56 0.02 1.17 5.63 2.83 0.03 1.13 7.05
Arrest 2.62 0.13 0.76 9.07 1.99 0.38 0.43 9.17
Uninsured 1.54 0.45 0.5 4.73 1.25 0.72 0.36 4.32
Lab-confirmed STI 1.20 0.65 0.54 2.71 0.71 0.49 0.27 1.87
1 or more current partner using PrEP 0.76 0.45 0.38 1.53 0.78 0.53 0.35 1.72
6+ months since last healthcare encounter 2.70 0.15 0.69 10.54 3.44 0.14 0.67 17.52
Anticipated discrimination in healthcare 0.50 0.07 0.23 1.06 0.51 0.13 0.21 1.23

At any point over follow-up. All other indicators were assessed at baseline only.